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This study scientifically examined the phytochemistry, antioxidant and antimicrobial potencies of two 
organic extracts of Pleurotus ostreatus. Generally, both extracts were effective against 89.8% of the 
isolates tested with Bacillus subtilis (7.6 – 7.8 mm), Escherichia coli (7.6 – 8.2 mm) and Saccharomycee 
cerevisae (10.5 – 10.8 mm) exhibiting highest gram ±ve, gram –ve and fungal susceptibilities by agar 
well diffusion method, respectively. However, petroleum ether extract (PE) exhibited greater anti-gram 
negative bacterial activity than the acetone extract (AE) and further produced growth inhibition of these 
isolates in broth. Compared to PE, the acetone extract elicited higher total phenolic content and in vitro 
antioxidant capacity. Phytochemical analyses of the extracts revealed low to moderate levels of 
terpenoids, tannins, steroidal glycosides and carbohydrates, while flavonoids, alkaloids and cynogenic 
glycosides were not detected. The results indicate that P. ostreatus possesses antimicrobial and 
antioxidant potentials. 
 





Edible mushrooms are nutritionally endowed fungi (mos-
tly Basidiomycetes) that grow naturally on the trunks, 
leaves and roots of trees as well as decaying woody ma-
terials (Chang and Miles, 1992; Stamets, 2000; Linde-
quist et al., 2005). Scientific explorations of Shiitake mus-
hrooms such as Lentinus edodes, Maitake mushrooms 
such as Grifola frondosa, chanterelles such as Chaterel-
lus carius, white button mushrooms such as Agaricus 
bisporus, and oyster mushrooms have shown that they 
serve as repositories of B-vitamins such as niacin, flavin 
and pyridoxine (Solomko and Eliseeva, 1988); organic 
acids such as ascorbate, shikimate, malate and fumarate; 
carbohydrates such as the -glucans; monoterpenoid and 
diterpenoid lipids; proteins such as hydrophobins and 
trace elements such as selenium (Dikeman et al., 2005; 
Valentao et al., 2005). These substances have been 
found through several in vitro and in vivo studies to be 
responsible for the antimicrobial, antioxidant, antitumor, 
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mushrooms (Lindequist et al., 2005). The recognition of 
Garnodema lucidium also called reshi as an antioxidant 
mushroom is due to its phenolic, terpenoids and poly-
saccharide polypeptide contents (Miller et al., 2000; Mau 
et al., 2002; Valentao et al., 2005). These bioactive com-
pounds mediate biological activities including stimulation 
of interleukin-12 production, nitric oxide synthase active-
tion, free radical scavenging and iron chelating properties 
(Cui et al., 2005; Acharya et al., 2005).  
Pleurotus ostreatus is among the edible mushrooms 
consumed in Nigeria. It is used as spice in vegetable 
soups and also fried to serve as meat (Annon, 2004). The 
mushroom is credited to be the third largest macrofungus 
cultivated for food and industial purposes worldwide. Nu-
tritionally, the mushroom has been found to contain vita-
mins B1 (thiamin), B2 (riboflavin), B5 (niacin), B6 (pyrido-
xine and B7 (biotin) (Solomko and eliseeva, 1988).  
The fruiting body of the mushroom is also a potential 
source of lignin and phenol degrading enzymes (Foun-
toulakis et al., 2002). While from clinical viewpoint, Bob-
eck and Galbavy (1999) showed that P. ostreatus elicited 
hypocholesterolemic and antherogenesis inhibition func-







However, unlike the fruiting bodies of few other edible 
mushrooms such as L. edodes, G. fondosa and G. luci-
dium known for exhibiting antibacterial and antifungal 
activity in vitro, there is lack of information on the micro-
bicidal properties of P. ostreatus coupled with inadequate 
data on its phytochemistry. It is hypothesized that know-
ledge of the phytoconsitituents of P. ostreatus would 
provide an insight into its biological functions beyond nut-
rition when consumed. In the present study, organic my-
celia extracts of P. ostreatus were phytochemically ana-
lysed and tested for antioxidant function in vitro. The anti-
microbial activity of these extracts was also examined. 
 
 




Strains of P. ostreatus sold as edible mushrooms in Lagos 
metropolis were brought at different locations in Lagos. They were 
identified at the Department of Pharmacognosy of the College of 
Medicine University of Lagos. A voucher specimen (PPL 001 - 002), 
was deposited in the Herbarium section at DANIFOL Biotechnology 
Consult Laboratory. The fruiting bodies, carefully removed from the 
hyphae were weighed then dried at 40oC for 24 h. The dried fruiting 




Preparation of Pleurotus ostreatus extracts  
 
Dried samples of fruiting body powder (3.5 g each) were separately 
extracted with 100 ml each of petroleum ether (20 – 80oC) and 80% 
acetone for 2 h using soxhlet apparatus. The residual solvent was 
removed by evaporation at 40oC for 24 h in vacuo using a rotatory 
evaporator. The resulting organic extracts were further reconstituted 
to different concentrations (0 – 100% v/v) with 0.1% Tween-20 in 
phosphate buffered saline (pH 7.2) followed by storage in sterile 




Phytochemical analysis of Pleurotus ostreatus extracts 
 
The phytoconstituents present in the organic extracts were deter-
mined qualitatively according to Sofowora (1993), Trease and 
Evans (1989) and Harbone (1973) as well as by thin layer chro-
matography (TLC). In TLC, the extracts spotted on silica coated 
plates, were developed using butanol-glacial acetic-water (100 : 10 
:10) as the solvent system. The developed plates were then spra-
yed with with vanillin solution (1% (w/v) in 50% phosphoric acid) for 
steroid detection, Dragendorff’s reagent for alkaloid detection and 
sodium metaperiodate (0.1%) followed by ethanolic benzidine for 
glucose detection. Nicotinic acid, cholesterol D-glucose and tannic 
acid at 1% solution were prepared accordingly and used as stan-
dards in the TLC assay.  The TLC results were further used to vali-
date the presence of tannins based on positive reaction (brownish 
green – blue black coloration) with 0.1% FeCl3, alkaloids based on 
positive reaction (brown coloration) with Dra-gendorff’s reagent 
(Trease and Evans, 1989; Sofowora, 1993),  steroids based on 
positive reactions (violet to blue or green) with acetic anhydride and 
H2SO4, steroidal glycosides by Keller-Killani test and cynogenic 
glycoside based red coloration of picrate paper (Harbone, 1973; 
Trease and Evans,  1993).  The observation of persistent frothing in 
distilled water (2 ml) by 1% standard saponin solution (3 ml) follow- 




ed by formation of emulsion with olive oil (0.5 ml) was used to 




Total phenolic content determination 
 
The total phenolic compounds present in the extracts were deter-
mined spectrophotometrically at 750 nm as described by Lee et al. 
(2001) using Folin-Ciocalteau pheno reagent. Standard solutions of 
gallic acid (20 – 200 mg/ml) were used to prepare a standard curve. 
The total phenolic contents of the extracts are expressed in milligr-
ams per ml of gallic equivalents (GAE) of triplicate measure-ments.  
 
 
Antioxidant activity determination 
 
The antioxidant activity of the P. ostreatus extracts was determined 
via the 2,2 – diphenylpicrylhydrazyl radical neutralization assay as 
described by Brand-Williams et al. (1995). Extracts were also tested 
as antioxidants using 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic 
acid (ABTS) assay (Cano et al., 1998). In both assays, 50 µl of 
each extract was added to with 950 µl of the free radical methanolic 
solution and stirred continuously for 15 min for DPPH or 10 min for 
ABTS. Decreases in absorbance were respectively measured at 
414 and 515 nm for ABTS and DPPH systems, respectively, and 
compared to that of infusion made from green tea a well-known 
antioxidant food (Cao et al., 1996). The infusion was prepared by 
boiling 1 g green tea bag with 100 ml of deionised water for 5 min. 
Antioxidant activity of the each extract was expressed as vitamin C 
equivalent antioxidant capacity (VCEAC) in millimolar (mM) by ex-
trapolation from the standard curve. Two – fold serial dilutions of L-
ascorbic acid (Aldrich, Germany) in deionised water to a final con-
centration range of 0.75 – 6.0 mM were used to prepare the cali-





The microorganisms to which the antimicrobial properties of the 
organic extracts of P. ostreatus were tested were obtained from the 
Departents of Biotechnology and Molecular Biology of the Nigerian 
Institute of Medical Research (NIMR), Yaba-Lagos. The bacterial 
isolates were multidrug resistant determined by disc diffusion assay 
according to Iwalokun et al. (2004) (Table 1). They were recovered 
as viable isolates by subculturing their stock cultures in 16% glyce-
rol-trypticase soy (TSB) or brain heart infusion broth (BHI) at –20oC 
or malt extraxt medium. The lactobacilli were recovered by growth 
in Mann Rogossa Sharpe (MRS) medium under anaerobic 
conditions (De Mann et al., 1960). Other bacterial isolates were 
recovered by growth on trypticase soy agar or blood agar under 
aerobic conditions at 37oC for 24 h. Aerobic growth at 30oC for 24 h 
on potato dextrose agar (PDA) was the basis for the recovery of 
Saccharomyces cerevisiae and Candida isolates tested. The 
recovered microbes were gram stained to confirm their gram reac-
tion status and speciated according to Cowan and Steel (1974). 
The gram-negative organisms include Escherichia coli, Salmonella 
typhi, Pseusomonas aeruginosa, Haemophillus influenza, while the 
gram-positive isolates were Bacillus licheniformis, Bacillus subtilis, 
Staphylococcus aureus, and Lactobacillus acidophilus  
Strains of Candida albicans ATCC 1880 and Sacharomyces 
cerevisiae were also tested to validate the antibiotic and extract 
susceptibility assays of the fungal isolates tested. 
 
 
Antimicrobial testing of Pleurotus ostreatus extracts 
 
P. ostreatus extracts were tested for antimicrobial activity by agar – 
well diffusion technique (Akpata and Akinrimisi, 1977) with a little
 




Table 1. Bacterial isolates and antibiotic resistance profiles. 
 
@Isolates N Antibiotic resistance 
Salmonella typhi 5 Cot, Col, Tet, Str, Chl, Amp 
Staphyloccocus aureus 8 Str, Amp, Pen, Amo, Aug 
Staphyloccocus epidermidis 4 Str, Amp, Amo, Pen 
Staphyloccocus aureus 2 Str, Amp, Amo, Aug, Pen, Met 
Escherichia coli  10 Cot, Col, Chl, Str, Tet 
Haemophillus influenzae 4 Ery, Str, Cot, Amo, Amp, Tet 
Proteus spp 5 Amp, Tet, Cot, Col, Str, Cot 
Pseudomonas aeruginosa 6 Str, Ery, Tet, Kan, Col, Cot, Amo 
Klebsiella pneumoniae 4 Amp, Tet, Str, TMP-STX 
†Lactobacillus acidophilus 8 Tet, Col 
 
@Isolates were grouped based on their display of 100% resistance to 
antibiotics by disk diffusion assay following identification according to 
Cowan and Steel (1974). N = number of isolates tested; Str = strep-
tomycin; Ery = erythromycin; Aug = augmentin; Cef = cefotaxime; Cro = 
ceftriaxone; Tet = tetracycline; Amp = ampicillin; Amo = amoxycillin; Kan = 
kanamycin; Gen = gentamicin; Chl = chloramphenicol; Col = colistin sul-
phate; cot = cotrimoxazole; and TMP-STX = Trimetoprim – sulphametho-
xazole. †The antibiotic resistance patterns of the isolates except L. acido-




modification. An overnight culture of each microbial isolate was 
emulsified with nutrient broth to a turbidity that was equivalent to 
0.5 McFarland (108 cfu/ml). 100 µl of each standard inoculum was 
then streaked on nutrient agar and PDA at 106 cfu/ml per spot to 
attain a confluent growth (Bauer et al., 1966). Wells were made on 
the agar using a sterile cork borer and filled with 100 µL P. ostrea-
tus organic extract. The plates were incubated accordingly as des-
cribed previously. Standard strain of E. coli ATCC 25922 was used 
as control organism for bacterial assays. Bacteria and fungal con-
trol wells contained 100 µl of ciprofloxacin and fluconazole, respect-
tively, at 5 µg per well. A well containing 100 µl of Tween-20-PBS 
solution (pH 7.2) was generally used as a positive control well in 
every assay. Growth inhibition was measured as diameters of 
inhibitory zones in the nearest 0.1 mm. 
 
 
Minimum inhibitory concentration (MIC) 
 
The MICs of the organic extracts were determined by broth dilution 
method according to Alade and Irobi (1993) with a little modifica-
tion. The extract was serially diluted with normal saline (0.85 g/dl) to 
5 –50 mg/ml preparations dispensed (1.0 ml) into test tubes con-
taining 1.0 ml of nutrient or potato dextrose broth. Each sensitive 
bacterial or fungal isolate (100 µl of 108cfu/ml) was inoculated into 
the test tubes. The tubes were mixed, covered with cotton wool and 
incubated appropriately as previously described. Thereafter, the 
tubes were then examined for microbial growth. The MIC was defi-
ned as the minimum concentration of the extract that did not allow 
any visible growth or turbidity of the organism in broth. MIC50 refers 
to concentration (%) of P. ostreatus required to prevent the growth 
of 50% of organisms tested. While MIC90 oil extract concentration, 





The present study has revealed the antibacterial and 
antifungal activity of petroleum – ether (PE) and acetone 
(AE) extracts of P. ostreatus fruiting body against multi 
drug resistant bacterial pathogens presented in Table 1. 
Data presented in Table 2 showed the fruiting body wet 
and dry weights per P. ostreatus strain analyzed ranged 
from 1.18 – 1.37 g (mean weight 1.27 ± 0.038 g) and 
0.126 – 0.174 g (mean weight 0.152 ± 0.0025 g), respect-
tively. The petroleum and acetone extract yields ranged 
from 3.32 – 3.40 mg / g dry mycelial weight yielding an 
average of 3.36 ± 0.01 mg/g dry weight.  
Phytochemical analysis revealed the presence of terpe-
noids, tannins, steroidal glycosides and carbohydrates in 
both extracts but with higher terpenoids contents in the 
PE fraction. Cyanogenic glycosides, alkaloids, flavonoids 
and anthraquinones were not detected in both extracts. 
Total phenol contents of 325.7 and 352.8 mg/L GAE were 
elicited by PE and AE extracts, respectively, and were 
further found to be significantly (P < 0.05) lower than 
1005.3 mg/L GAE  (P < 0.05) in the green tea infusion 
used as standard (Figure 1). 
Preliminary antimicrobial testing of petroleum ether ext-
ract of P. ostreatus by agar-well diffusion produced zones 
of growth inhibition of 3.0 – 7.8 ± (0.1 – 0.9) mm for the 
gram positive bacteria, 5.0 – 8.2 ± (0.1 – 0.7) mm for the 
gram negative bacteria and 8.1 – 10.8 ± (0.1 – 1.6) mm 
for the fungal isolates tested (Table 3). Among the sus-
ceptible gram-negative bacteria tested, inhibitory zones 
due to petroleum extract were higher than those of the 
acetone extract.  
Among the gram-positive bacteria tested, local isolates 
of L. acidophilus (2 of 8) and B. subtilis (5 of 5) were obs-
erved to be the least [3.0-3.2 ± (0.1 - 0.2) mm] and most 
[7.6 - 7.8 ± (0.2-0.8) mm] sensitive strains in both organic 
extracts. In gram-negative bacteria, local isolates of E.
 




Table 2. Oil yield and phytochemical analysis of extracts of Pleurotus ostreatus mycelium. 
 
Parameter Amount 
Fruiting body wet weight (g) / strain 1.18 – 1.37 (1.27 ± 0.038) 
Fruiting body dry weight (g) / strain 0.126 – 0.174 (0.152 ± 0.0025) 
Extract yield (mg/g dry weight) 3.32 – 3.40 (3.36±0.01) 
Phytoconstituents 
 PE AE 
Terpenoids ±± ± 
Tanins ± ± 
Steroidal glycosides ± ± 
Carbohydrates ± ± 






Figure 1. Total phenolic content of Pleurotus ostreatus 
extracts compared to green tea. AE = acetone extract; PE = 




coli and H. influenzae exhibited the highest [7.6 – 8.2 ± 
(0.7 –0.8) mm] and lowest [5.0 - 5.5 ± (0.5-0.7) mm] sus-
ceptibilities, respectively. Furthermore, highest suscepti-
bility [10.5 - 10.8 ± (1.2-1.6) mm] by S. cerevisiae strains 
(4 of 4) and lowest susceptibility [8.0-8.1 ± (0.1-0.3) mm] 
by C. albicans ATCC1880 were observed among the 
fungal isolates. On the whole, 79 (89.8%) of the 88 isola-
tes tested showed sensitivity to acetone and petroleum 
ether extracts of P. ostreatus (Table 3). 
The petroleum ether extract of P. ostreatus further sho-
wed stronger inhibition of these organisms in broth com-
pared to the acetone extract (results not shown) with 
MICs of 78.3 – 100.0 ± (0 – 4.1)% extract for gram posi-
tive bacteria with Staphylococcus sp. having mean MIC50 
and MIC90 of 71.7 ± 2.9 and 79.2 ± 8.8%, respectively.  
The two sensitive L. acidophilus were inhibited with MIC90 
of 100% extract, equivalent to the MIC (Table 4). The 
inhibition of gram-negative bacteria: S. typhi and E. coli 
by PE was observed at lower MICs (72.5 – 75.0%), MIC50 
(66.3 – 67.5%) and MIC90 (71.3 – 72.5%). The PE also 
caused growth inhibition of the fungal isolates tested in 
potato dextrose medium with MICs of 70.0 ± 3.5% and 
67.5 ± 3.4% for Candida sp. and S. cerevisiae, res-
pectively (Table 4).  
Antioxidant activty of the extracts by DPPH and ABTS 
methods revealed a disparate VCEACs  of 3.6 – 3.8 mM 
for PE and 4.1 – 4.4 mM for AE (P > 0.05) compared to 






P. ostreatus, an oyster mushroom is primarily consumed 
for its nutritive value and used industrially as a bioreme-
diator (Solomko and Eliseeva, 1988; Fountoulakis et al., 
2002; Tsioulpas et al., 2002). The present study has fur-
ther revealed the antimicrobial potency of the oil of the 
macrofungus extracted with petroleum ether and ace-
tone. Both extracts were observed to inhibit gram positive 
and gram-negative bacteria as well as fungi tested in vitro 
to suggest that P. ostreatus has a broad-spectrum anti-
bacterial and antifungal activity. Similar antimicrobial pot-
entials have been observed in the culture extracts of Irp-
ex lacteus (Rosa et al., 2003) Agrocybe sp. (Kavanagh et 
al., 1950; Mavoungou et al., 1987), and juice of L. edodes 
(Kuznetsov et al., 2005). Antimicrobial potencies of the 
essential oils from mushrooms such as Cuminum cymi-
num, carum carvi, Coriandum sativum and Foeniculum 
vulgare have also been reported (Iacobellis et al., 2005) 
with activity against bacterial pathogens such as Pseudo-
monas, Klebsiella, Salmonella and E. coli as observed for 
P. ostreatus in this study. 
The observed disparity in the the susceptibilities of 
gram-ve bacteria tested with petroleum ether extract elici-
ting greater effect provides an indication that the organic 
solvents used have varyning abilities to extract bioactive 
substances  from  P.  ostreatus. This  is further evidenced 
 





Table 3. Preliminary antimicrobial testing of Pleurotus ostreatus extracts. Inhibition zone diameter (mm ± SD)* 
 
Pleurotus ostreatus @Isolates 
PE AE 
Standard drugs# 0.1% (v/v) Tween-20 
Gram - positive bacteria 
Staphylococcus aureus ATCC 25923 7.5 ± 0.1 7.6 ± 0.3 27.5 ± 0.7 G 
Staphylococcus aureus (8) 7.2 ± 0.9 7.1 ± 0.7 27.7 ± 0.9 G 
Staphylococcus aureus (2) 7.0 ± 0.8 7.0 ± 0.6 28.1 ± 0.4 G 
Staphylococcus epidermidis (4) 7.1 ± 0.8 7.0 ± 0.7 29.1 ± 0.5 G 
Bacillus subtilis ATCC 6633 7.1 ± 0.1 7.2 ± 0.2 27.8 ± 0.3 G 
Bacillus subtillis (5) 7.8 ± 0.2 7.6 ± 0.8 28.4 ± 0.6 G 
Bacillus licheniformis (10) 7.7 ± 0.2 7.7 ± 0.4 27.8 ± 0.4 G 
†Lactobacillus acidophilus (2) 3.0 ± 0.2 3.2 ± 0.1 28.9 ± 0.4 G 
Gram –negative bacteria 
Salmonella typhi ATCC 13391 7.5 ± 0.1 7.2 ± 0.4 28.1 ± 0.1 G 
Salmonella typhi (5) 7.2 ± 0.3 7.0 ± 0.1 28.4 ± 1.3 G 
Escherichia coli ATCC25922 7.0 ± 0.0 7.0 ± 0.0 29.5 ± 0.1 G 
Escherichia coli (10) 8.2 ± 0.7 7.6 ± 0.8 28.5 ± 1.0 G 
Proteus sp. (3) 6.9 ± 0.5 6.5 ± 0.6 27.8 ± 0.7 G 
Klebsiella pneumoniae (4) 7.1 ± 0.2 7.0 ± 0.1 28.0 ± 0.1 G 
††Pseudomonas aeruginosa (3) 5.6 ± 0.4 5.2 ± 0.2 28.2 ± 0.6 G 
Haemophillus influenzae (4) 5.5 ± 0.5 5.0 ± 0.7 27.7 ± 0.9 G 
Fungi isolates     
Candida albicans ATCC 1880 8.1 ± 0.1 8.0 ± 0.3 28.4 ± 0.0 G 
Candida sp. (10) 8.2 ± 0.3 8.3 ± 0.1 28.2 ± 0.7 G 
Saccharomyces cerevisiae (4) 10.8 ± 1.2 10.5 ± 1.6 28.8 ± 0.6 G 
 
Figures in parentheses represent the number of isolates tested; † All and two of the tested L. acidophilus strains were sensitive 
to ciprofloxacin and P. ostreatus, respectively. †† Three (3) of the ciprofloxacin sensitive Pseudomonas aeruginosa isolates (6 
0f 6) were also sensitive to P. ostreatus. G = Bacterial growth around the in phosphate buffered 0.1% Tween-20 control wells; 
# = growth inhibition zones for ciprofloxacin (5µg per well) and fluconazole (5µg per well) used as standard drugs. *The 
diameters of zone of inhibition were expressed in millimeter (mm) as mean ± standard deviation.  @Seventy-nine (89.8%) of the 
88 isolates showed sensitivity to P. ostreatus. PE = Petroleum ether extract; AE = Acetone extract. 
 
 
Table 4. Minimum inhibitory concentrations determinations of Pleurotus ostreatus petroleum ether extract 
against multidrug resistant bacteria and yeasts. 
 
MIC (% extract) Isolates 
MIC50 MIC90 
MIC 
Gram - positive bacteria 
Staphylococcus aureus (15) 71.7 ± 2.9 79.2 ± 8.8a 80.3 ± 4.1a 
Bacillus sp. (16)  70.8 ± 5.2 74.5 ± 4.3 78.3 ± 3.8 ab 
Lactobacillus acidophilus (2) ND 100.0 ± 0.0 100.0 ± 0.0 
Gram –negative bacteria 
Salmonella typhi (10) 66.3 ± 4.8 72.5 ± 6.5a 75.0 ± 5.1a 
Escherichia coli (15) 67.5 ± 2.9 71.3 ± 7.5 71.3 ± 7.5 
Proteus sp. 83.8 ± 4.8 90.1 ± 4.1a 92.6 ± 4.4a 
Pseudomonas aeruginosa (3) 91.7 ± 2.9 100.0 ± 0.0a 100.0 ± 0.0a 
Klebsiella pneumoniaa (4) 75.0 ± 4.1 80.0± 4.1a 88.6 ± 2.6 ab 
Haemophillus influenzae (2) 88.1 ± 2.4 95.0 ± 4.1 100.0 ± 0.0a 
Fungi isolatesCandida sp. (10) 65.0 ± 5.0 70.0 ± 3.5a 70.0 ± 3.5a 
Saccharomyces cereviciase (4) 62.7 ± 3.8 65.0 ± 4.2 67.5 ± 3.4a 
 
Data are presented as mean ± SD of experiments in duplicates. Figures in parenthneses indicate the number of isolates 
tested. in duplicates. Disparity between mean values was analyzed by student’s t- test. aP < 0.05 ( MIC50 vs. MIC90 or 
































Figure 2. Antioxidant capacity of P. ostreatus extracts compared 
to green tea. Data are mean ± SEM of 3 determinations; AE and 
PE = Acetone and petroleum ether extract, respectively. aP< 





by the different levels of terpenoids and phenolics obser-
ved in the two organic extracts. A clue that the petroleum 
extract may have greater antibacterial potential was pro-
vided by the observed MIC50 and MIC90 inhibitory concen-
trations of the extract against S. aureus, S. typhi and 
Candida isolates tested. Similar antibacterial characteris-
tics have been observed in fluoroquinolones such as 
ciprofloxacin (Iwalokun et al., 2001) and medicinal plants 
such as Ocimum gratissimum (Iwalokun et al., 2003). 
Meanwhile, terpenoids have been implicated as the phy-
toconstituents responsible for the antibacterial activity of 
mushrooms including Cuminum cyminum and Carum car-
vi (Iacobellis et al., 2005). The observed phenolic and 
tannin conctituents of P. ostreatus may also elicit anti-
bacterial activity as found in many medicinal plants with 
mechanisms of action characterized by cell membrane 
lysis, inhibition of protein synthesis, proteolytic enzymes 
and micriobial adhensins (Cowan, 1999).  
However, the observed insensitivity of 6 of 8 L. acido-
philus and 3 of 6 P. aeruginosa isolates tested to P. ost-
reatus extracts implies that strain variation may deter-
mine susceptibility of bacteria to antibacterial agents from 
mushrooms. A recent study by Kuznetzov et al. (2005) 
also revealed the insensitivity of Bifidobacteria and Lacto-
bacilli to the antibacterial action of L. edodes juice. How-
ever, the observed inhibition of the S. cerevisiae strains 
tested by P. ostreatus agrees with the findings of Hwang 
et al. (2000) in which Phellinus sp. were found to halt the 
growth of S. cerevevisiae with an IC50 value of 76 g/ml 
via chitin synthase inhibition. These observations may 
confer ecological and metabolic benefits to edible mush-
rooms since lactic acid bacteria may act synergistically to  




improve the nutritional quality and shelf life of associated 
fermented foods (Okamura-Matsui et al., 2001) and yeast 
contamination has been implicated in the decay of mush-
rooms (Middlelhoven, 2004). However, the observed gro-
wth inhibition halos (5.5 – 10.1 mm) produced by P. ostr-
eatus were lower than > 12.0 mm halos produced by I. 
lateus as reported by Rosa et al. (2003) but comparable 
to halos produced by Agaricus sp., Gloedoporus thele-
phoroides and Coprinus sp. reported by the same 
workers. 
The reported variations in the antimicrobial outcomes of 
these macrofungus may not be unconnected with their 
species and strain variations, differences in their microbi-
cidal composition and concentrations, in the method of 
extraction and mechanism of actions of active principles 
in these edible mushrooms. Antibacterial agents such as 
agrobycin from Agrocybe sp (Kavanagh et al., 1950) and 
marasmic acid from Marasmius conigenus have been 
observed to elicit activity at microgram per ml concentra-
tions. Guo et al. (2005) recently isolated trichogin, an an-
tifungal protein from Tricholoma giganteum and found the 
protein exhibiting HIV-1 reverse transcriptase inhibition 
with an IC50 of 83 nM.  
Other bioactive antimicrobial compounds that have also 
been isolated from edible basidiomycetes include glauco-
pines from Sarcodon glaucopus, pleuromutilin and chan-
terellins from chanterelle mushrooms (Curini et al., 2005; 
Kavanagh et al., 1950).  
These substances masquerade as phenolics and terpe-
noids (Mothana et al., 2000), which were also detected in 
P. ostreatus. Therefore, there is no doubt that the future 
determination of the structure and functions of the phe-
nolic and terpenoid constituents of P. ostreatus would 
further validate its antimicrobial potentials. 
The present study also observed P. ostreatus to elicit 
antioxidant capacity using the DPPH and ABTS methods 
thereby expanding its nutraceutical values. However, the 
observed VCEAC (3.6 – 4.4 mM) for P. ostreatus is lower 
than values reported for some selected Indian medicinal 
mushrooms including G. lucidum by Lakshmi (2004) and 
Button mushrooms by Miller et al. (2000) with antioxidant 
capacity mostly attributed to their phenolic contents, the 
antioxidant properties of polysaccharide and polysaccha-
ride peptides of G. lucidum being an exception (You and 
Lin, 2003). However, the observed higher phenolic con-
tents and antioxidant capacity in the acetone extract of P. 
ostreatus compared to the petroleum extract provides an 
indication for a superiority of acetone over petroleum et-
her in the exudation of antioxidant substances from P. 
ostreatus.  
Flavonoids, which are also phenolic compounds with 
antioxidant activity (Mau et al., 2002; Gil et al., 2000) 
were not detected in P ostreatus. Our observation agrees 
with findings of Mattila et al. (2001) and according to 
USDA, mushrooms are regarded as non-sources of fla-
vonoids. The absence of flavonoids in mushrooms may 
be of biological advantage in their various ecological nic- 
 




hes since these bioactive compounds inhibit enzyme acti-
vities (e.g. tyrosinase) involved in their pigmentation, 
growth and development (Xie et al., 2003).   
The low and varied phenolic contents of P. ostreatus, 
could also emanate from the differences in the mycelial 
wet and wet weights of the tested in this study. This may 
be attributed to the variations in their growth conditions 
since they were not cultivated in the same location. The 
works of Nwanze et al. (2005a, 2005b) on Lentinus squa-
rrosulus and Psathyrella atroumbonata showed that both 
media composition and oil type influence the mycelial bio-
mass of these mushrooms. Therefore, appreciable amo-
unt of extract and thus phenolic compounds and terpe-
noids can be recovered from P. ostreatus if its optimum 
growth condition is known. This may further enhance its 
medicinal and market values. 
Based on the results of this study, it can be concluded 
P. ostreatus, an edible oyster mushroom has antioxidant 
potentials and possess a broad-spectrum antibacterial 
and antifungal activity, optimisable by multiple organic 
mycelia extraction. Further investigations that would iden-
tify the active phenolic and terpenoid compounds and 
determine the optimal mycelial growth conditions of P. 
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